Last reviewed · How we verify
NCT06710392: ElZyme
Efficacy of Two Enzyme Cocktails in Healthy Adults
NA trial testing Enzyme Cocktail A in Digestive in 100 participants. Not yet recruiting.
30 November 2025
Quick facts
| Lead sponsor | The Archer-Daniels-Midland Company |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 15 December 2024 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Enzyme Cocktail A
- Enzyme Cocktail B
- Placebo A
- Placebo B
Conditions studied
- Digestive — all drugs for Digestive →
- Gastrointestinal Health — all drugs for Gastrointestinal Health →
Sponsor
The Archer-Daniels-Midland Company
Who can join
Adults 18 to 65, any sex, with Digestive or Gastrointestinal Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to determine the safety and efficacy of two enzyme cocktails in healthy adults with mild to moderate gastrointestinal discomfort. The main question aims to answer whether a 4-week administration of an enzyme cocktail can improve how the participant feels about their gut health. This is done by completing a weekly questionnaire, and the results are compared between the 4 weeks the participants are on a placebo and the 4 weeks the participants are on the enzyme cocktail. Participants will also provide a stool sample at the start and end of each treatment. Stool samples will collected and stored in case further microbiome analysis is warranted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06710392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Archer-Daniels-Midland Company trials
Trials by the same sponsor.
- NCT06701604 — Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding · NA · not yet recruiting
- NCT05562739 — Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety · NA · completed
- NCT06103994 — Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination · NA · completed
- NCT06047145 — Evaluation of Soy Isoflavones on Skin Ageing Parameters · NA · completed
- NCT06083311 — The Efficacy of a Probiotic for Functional Constipation (FC) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06710392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Archer-Daniels-Midland Company
- Last refreshed: 29 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06710392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing